ID19063A - Pereaksi peptida untuk deteksi cytomegalovirus (cmv) - Google Patents
Pereaksi peptida untuk deteksi cytomegalovirus (cmv)Info
- Publication number
- ID19063A ID19063A IDP972439A ID972439A ID19063A ID 19063 A ID19063 A ID 19063A ID P972439 A IDP972439 A ID P972439A ID 972439 A ID972439 A ID 972439A ID 19063 A ID19063 A ID 19063A
- Authority
- ID
- Indonesia
- Prior art keywords
- cmv
- detection
- antibodies
- cytomegalovirus
- peptidic
- Prior art date
Links
- 241000701022 Cytomegalovirus Species 0.000 title abstract 6
- 238000001514 detection method Methods 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 239000012530 fluid Substances 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 241000701024 Human betaherpesvirus 5 Species 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
- C07K16/089—Cytomegalovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96201972 | 1996-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID19063A true ID19063A (id) | 1998-06-11 |
Family
ID=8224180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP972439A ID19063A (id) | 1996-07-12 | 1997-07-14 | Pereaksi peptida untuk deteksi cytomegalovirus (cmv) |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6936251B2 (xx) |
| EP (1) | EP0960336B1 (xx) |
| JP (1) | JP4218985B2 (xx) |
| KR (1) | KR100624517B1 (xx) |
| AT (1) | ATE225942T1 (xx) |
| AU (1) | AU735981B2 (xx) |
| DE (1) | DE69716305T2 (xx) |
| DK (1) | DK0960336T3 (xx) |
| ES (1) | ES2187796T3 (xx) |
| ID (1) | ID19063A (xx) |
| WO (1) | WO1998002746A1 (xx) |
| ZA (1) | ZA976196B (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19919121B4 (de) * | 1999-04-27 | 2012-08-02 | F. Hoffmann-La Roche Ag | Multimeres CMV-Antigen |
| US6544521B2 (en) | 2000-10-20 | 2003-04-08 | City Of Hope | Immunoreactive peptide CTL epitopes of human cytomegalovirus pp150 |
| AUPR593101A0 (en) * | 2001-06-26 | 2001-07-19 | Council Of The Queensland Institute Of Medical Research, The | Cytomegalovirus t cell epitopes |
| ITMI20012160A1 (it) * | 2001-10-18 | 2003-04-18 | Edoardo Marchisio | Sistema immunoenzimatico per la caratterizzazione antigenica dell'infezione attiva da cytomegalovirus e cmv confirmation test |
| US7947274B2 (en) | 2007-01-04 | 2011-05-24 | Humabs, LLC. | Human cytomegalovirus neutralising antibodies and use thereof |
| GB0700133D0 (en) | 2007-01-04 | 2007-02-14 | Humabs Llc | Human cytomegalovirus neutralising antibodies and use thereof |
| BRPI0807095A2 (pt) * | 2007-02-07 | 2014-04-22 | Sigma Tau Ind Farmaceuti | Antígenos recombinantes de citomegalovírus humano (hcmv) |
| PE20141434A1 (es) | 2008-07-16 | 2014-10-22 | Inst Research In Biomedicine | Anticuerpos neutralizantes de citomegalovirus humano |
| EP2471553A4 (en) * | 2009-06-26 | 2013-08-28 | Vectorite Biomedica Inc | IMMUNOGENIC COMPOSITION WITH PEPTIDES FROM CYTOMEGALOVIRUS AND THEIR USE |
| JP5712513B2 (ja) * | 2010-07-07 | 2015-05-07 | 富士レビオ株式会社 | ヒトサイトメガロウイルス感染の検出方法 |
| NZ591514A (en) * | 2011-03-03 | 2013-11-29 | Kode Biotech Ltd | Assay method |
| US10611800B2 (en) | 2016-03-11 | 2020-04-07 | Pfizer Inc. | Human cytomegalovirus gB polypeptide |
| US11629172B2 (en) | 2018-12-21 | 2023-04-18 | Pfizer Inc. | Human cytomegalovirus gB polypeptide |
| US11857622B2 (en) | 2020-06-21 | 2024-01-02 | Pfizer Inc. | Human cytomegalovirus GB polypeptide |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE110084T1 (de) * | 1985-12-06 | 1994-09-15 | Teijin Ltd | Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung. |
| CA1335429C (en) * | 1986-03-07 | 1995-05-02 | Geoffrey L. Smith | Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor |
| DE3619902A1 (de) * | 1986-06-13 | 1988-03-03 | Biotechnolog Forschung Gmbh | Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung |
| ES2081289T3 (es) * | 1988-02-24 | 1996-03-01 | Behringwerke Ag | Fosfoproteina estructural (pp28) del citomegalovirus humano (hcmv), su preparacion y empleo. |
| GB9014652D0 (en) * | 1990-07-02 | 1990-08-22 | Wellcome Found | Antigen |
| DE4128684A1 (de) * | 1991-08-29 | 1993-03-04 | Behringwerke Ag | Hcmv-spezifische peptide, mittel dazu und ihre verwendung |
| US5744298A (en) * | 1991-08-29 | 1998-04-28 | Behringwerke Aktiengesellschaft | DNA sequences which encode immunoreactive HCMV-specific peptides |
| IT1266740B1 (it) * | 1994-07-01 | 1997-01-14 | Maria Paola Landini | Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale |
| EP0702083A3 (de) * | 1994-07-26 | 1997-01-15 | Biotest Ag | Polypeptide und Fusionsproteine bestehend aus dem UL 57 Leserahmen bzw. dem C-terminalen Bereich des Tegumentproteins pp150 aus HCMV, entsprechende Oligonucleotide und Nachweis reagentien |
| DE4426453C1 (de) * | 1994-07-26 | 1995-11-02 | Biotest Ag | Rekombinant hergestellte Fusionsproteine des Cytomegalievirus und diese enthaltende diagnostische Testkits |
-
1997
- 1997-07-09 JP JP50560998A patent/JP4218985B2/ja not_active Expired - Lifetime
- 1997-07-09 WO PCT/EP1997/003717 patent/WO1998002746A1/en active IP Right Grant
- 1997-07-09 DK DK97932819T patent/DK0960336T3/da active
- 1997-07-09 ES ES97932819T patent/ES2187796T3/es not_active Expired - Lifetime
- 1997-07-09 KR KR1019997000160A patent/KR100624517B1/ko not_active IP Right Cessation
- 1997-07-09 EP EP97932819A patent/EP0960336B1/en not_active Expired - Lifetime
- 1997-07-09 DE DE69716305T patent/DE69716305T2/de not_active Expired - Lifetime
- 1997-07-09 AT AT97932819T patent/ATE225942T1/de not_active IP Right Cessation
- 1997-07-09 AU AU36231/97A patent/AU735981B2/en not_active Expired
- 1997-07-11 ZA ZA976196A patent/ZA976196B/xx unknown
- 1997-07-14 ID IDP972439A patent/ID19063A/id unknown
-
2002
- 2002-11-05 US US10/288,220 patent/US6936251B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6936251B2 (en) | 2005-08-30 |
| AU3623197A (en) | 1998-02-09 |
| KR100624517B1 (ko) | 2006-09-18 |
| ZA976196B (en) | 1998-09-01 |
| ATE225942T1 (de) | 2002-10-15 |
| WO1998002746A1 (en) | 1998-01-22 |
| US20030119039A1 (en) | 2003-06-26 |
| AU735981B2 (en) | 2001-07-19 |
| KR20000023701A (ko) | 2000-04-25 |
| JP2000514300A (ja) | 2000-10-31 |
| ES2187796T3 (es) | 2003-06-16 |
| EP0960336B1 (en) | 2002-10-09 |
| DE69716305D1 (de) | 2002-11-14 |
| EP0960336A1 (en) | 1999-12-01 |
| DK0960336T3 (da) | 2003-02-10 |
| JP4218985B2 (ja) | 2009-02-04 |
| DE69716305T2 (de) | 2003-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID19063A (id) | Pereaksi peptida untuk deteksi cytomegalovirus (cmv) | |
| BR9809443A (pt) | Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão. | |
| DK104093D0 (da) | Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen | |
| DE60139326D1 (de) | Detektion von peptiden | |
| BR9712298A (pt) | Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão | |
| HUP0103650A2 (hu) | Vírusburok-proteinek epitópjai és az ellenük termelt ellenanyagok alkalmazása HCV-vírusantigén gazdaszövetből történő kimutatására | |
| SE9500023D0 (sv) | Method of detecting cancer | |
| EP2048505A3 (de) | Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers | |
| ATE258310T1 (de) | Testverfahren für collagenpeptid | |
| GR3018371T3 (en) | Method for identifying or determining proteins and applications therefor. | |
| DE69638024D1 (de) | Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren | |
| ATE366420T1 (de) | Kit und verfahren zur bestimmung von protein esm- 1 | |
| DK0747481T3 (da) | Epstein-Barr-viruspeptider og antistoffer mod disse peptider | |
| AU5505198A (en) | Methods for diagnosis of allergic bronchopulmonary aspergillosis | |
| ATE306666T1 (de) | Verfahren zur eiweissanalyse | |
| DK0607425T3 (da) | Epstein-Barr-viruspeptider og antistoffer mod disse peptider | |
| CA2259967A1 (en) | Peptide reagent for the detection of human cytomegalovirus (cmv) | |
| NO983984L (no) | Disintegrin-metalloprotease samt anvendelse derav | |
| ATE228249T1 (de) | Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm | |
| WO2001015655A3 (en) | Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders | |
| ATE271067T1 (de) | An menschliches wachstumshormon (hgh) bindende monoklonale antikörper | |
| AR013326A1 (es) | POLIPEPTIDO AISLADO, MOLECULA DE ADN, VECTOR DE EXPRESION RECOMBINANTE, CELULA HUESPED, METODO PARa DETECTAR LA INFECCION DE M.TUBERCULOSIS EN UNAMUESTRA BIOLOGICA, EQUIPO PARA DIAGNOSTICO, ANTICUERPO MONOCLONAL, Y ANTICUERPO POLICLONAL, PROTEINAS DE FUSION |